Quantum BioPharma Ltd. Board of Directors

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.

Mr. Zeeshan Saeed

Mr. Zeeshan Saeed

Founder, CEO, President & Executive Co-Chairman

Mr. Anthony John Durkacz

Mr. Anthony John Durkacz

Founder & Executive Co-Chairman

Dr. Andrzej Chruscinski M.D., Ph.D.

Dr. Andrzej Chruscinski M.D., Ph.D.

Vice President of Clinical & Scientific Affairs of Lucid

Mr. Kevin Cassidy

Mr. Kevin Cassidy

Vice President of Quality-Lucid

Mr. Jason D. Sawyer

Mr. Jason D. Sawyer

Head of Finance & Mergers and Acquisitions

Randell Mack

Randell Mack

President of FSD BioSciences

Ms. Maryann Adesso

Ms. Maryann Adesso

Corporate Secretary

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.